GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
2.220
-0.020 (-0.89%)
At close: Jan 17, 2025, 4:00 PM
2.163
-0.057 (-2.56%)
After-hours: Jan 17, 2025, 6:59 PM EST
GeoVax Labs Employees
GeoVax Labs had 17 employees as of December 31, 2023. The number of employees increased by 3 or 21.43% compared to the previous year.
Employees
17
Change (1Y)
3
Growth (1Y)
21.43%
Revenue / Employee
$181,774
Profits / Employee
-$1,430,709
Market Cap
20.95M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
GOVX News
- 6 weeks ago - GeoVax Receives Notice of Allowance For Cancer Vaccine Patent - GlobeNewsWire
- 7 weeks ago - GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference - GlobeNewsWire
- 2 months ago - GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024 - GlobeNewsWire
- 3 months ago - GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
- 4 months ago - GeoVax to Participate in Upcoming Investor Conferences in September - GlobeNewsWire
- 5 months ago - GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market - GlobeNewsWire